Research Grade Biosimilars Antibodies
Absolute Antibody provides a range of research-grade biosimilar antibodies, including Trastuzumab, Gemtuzumab, Rituximab, Infliximab, Daclizumab, Basiliximab, Cetuximab, and Eculizumab. Each biosimilar is available in the original human format and can also be customized with a mouse, rabbit, rhesus monkey, or cynomolgus monkey constant domain.
Place your order directly with the manufacturer.
Absolute Antibody research-grade biosimilar antibodies can be used as controls to benchmark novel biotherapeutics (biologics) for pre-clinical lead identification and for the development of potency assays. Each biosimilar antibody is supplied in PBS buffer with preservative and adheres to the following specifications:
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Purity is > 96% as determined by SDS-PAGE
CONJUmAbs research-grade biosimilar antibodies from Absolute Antibody are carrier free products specifically designed for Antibody Drug Conjugate research. These concentrated, high purity, and low endotoxin antibodies are formulated to make your conjugation procedure easier. Trastuzumab, Gemtuzumab, and Cetuximab can be purchased off-the-shelf, with other CONJUmAbs biosimilar antibodies available upon request.
- Concentrated – 5 mg/ml concentration eliminates the need to concentrate before conjugation
- High Purity – Additional purification step results in > 99% purity and > 98% monomer by SEC-HPLC
- Low Endotoxin – < 0.5 EU/mg endotoxin suitable for in vivo and in vitro use
- Carrier Free – Formulated without the use of Proclin 300, sodium azide, BSA, and other excipients
Absolute Antibody research-grade biosimilars are NOT FOR THERAPEUTIC USE.
